Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) this morning announced the creation of four new wholly-owned subsidiary companies: Lexaria CanPharm Corp., a Canadian company that provides DehydraTECH technology and other enhancements to the global cannabis industry; Lexaria Nicotine Corp., a US company with a global license to offer DehydraTECH technology to the global nicotine and tobacco industries; Lexaria Hemp Corp., a US company globally licensed to provide DehydraTECH to the burgeoning hemp-based foods and supplements industries; and Lexaria Pharmaceutical Corp., a US company internationally authorized to license DehydraTECH to the pharmaceutical sector, including pain relief, vitamins, hormone treatments, central nervous system conditions and more. To greater engage with the separate customer bases and business applications for each subsidiary, this new corporate structure enables Lexaria to focus its future research, potential financing structures and industry partnerships on options specifically suited for each new subsidiary. The company also plans to use wholly-owned Poviva Tea Corp. to advance the current ViPova Tea and Coffee consumer brands. In addition, Lexaria announced that it has received $33,000 from the exercise of 330,000 options at the price of $0.10 previously granted to a third party. The proceeds will be used for general corporate purposes.
To view the full press release, visit http://nnw.fm/n9tZ9
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. licenses disruptive patented delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECH™ delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.
More from NetworkNewsBreaks
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]